News & Articles

Working with the UK government, first vaccinations are to begin early in the new year

The real-time RT-PCR assay can simultaneously detect and differentiate 8 target genes, the first and only test to do so in the world

Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein

Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape

The research helps shed light on genes responsible for a shield-like capsule that could help protect some bacteria from our immune system, making them deadly

Explore ways to improve time to result in critical pathways such as sepsis

HALIX to provide large-scale GMP manufacture of AZD1222

In a 17-4 vote, the FDA vaccine advisory committee recommended that Pfizer/BioNTech’s COVID-19 vaccine should be distributed to the U.S.

Parties to collaborate on development, commercialization, and supply of the Orgenesis therapies pipeline

Join us on Thursday, December 10, to discover how to rapidly diagnose antimicrobial resistance for appropriate therapy

Dr. Chris Mason shares his extensive research into the SARS-CoV-2 immune response and the similarities experienced by astronauts landing back on Earth

Designed to enrich pathologists' skills in biomarker interpretation and scoring techniques

Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection

Two different dosing regimens demonstrated efficacy with one showing a better profile

The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic

Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported

The new lots further enhance Lonza’s renowned human primary cell offerings as it looks to meet growing market demand for deeper cell characterization

Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing

QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes

Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide

The kit promises to be a low cost, high-sensitivity diagnostic test for COVID-19 detection

The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR

Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development

This project aims to produce an antiviral and antifouling coating which can be used on PPE to protect staff working in healthcare settings